#AutonomousLabs

@larrymyork.phenotyper.com

2 weeks ago

Forced a collision in our plate imaging robot to demonstrate something more important than automation: safe failure and deterministic recovery.

Autonomy only works if safety is engineered first. Agentic layer coming up.

#AutonomousLabs #GenesisMission

0 0 0 0

Larry M. York

@larrymyork.phenotyper.com

3 weeks ago

LLMs don’t actually use tools. They’re stateless: text in, text out. “Tool use” is orchestration — structured text that systems parse and execute in between. #AutonomousLabs #GenesisMission

1 1 0 0

Larry M. York

@larrymyork.phenotyper.com

1 month ago

Excited to share our first fully integrated prototype, safety-compliant robotic plate imaging workcell at ORNL—complete with enclosure, Banner SC10 controller, door interlocks, and protective stop with a uFactory xArm 5.

#GenesisMission #AutonomousLabs #Robotics #OpenScience #LabAutomation

4 0 1 0

Larry M. York

@larrymyork.phenotyper.com

1 month ago

Excited to demo the first safety control system for our robotic workcell. As labs become more automated, it’s easy for safety to lag - getting it right early has been eye-opening. More to share soon as the COBOT Autonomous Lab continues to develop.
#MachineSafety #AutonomousLabs #GenesisMission

0 0 0 0

Industry Examiner

@industryexaminer.bsky.social

5 months ago

The AI science factory arrives: why Lila’s $1.3bn valuation matters beyond biotech - Biotech Industry Examiner Lila’s Nvidia-backed raise is about more than money. It is an attempt to industrialise discovery—and to sell it as capacity to pharma, chipmakers and energy

Lila Sciences adds $115M (Series A $350M, >$1.3B). Thesis: AI-run robotic labs that sell discovery capacity to biotech, chips & energy. KPIs to watch: utilisation, cycle time, software→factory conversion. Our take👇
biotech.industryexaminer.com/lila-ai-scie...
#Biotech #AI #AutonomousLabs #TechNews

0 0 0 0